Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

2.

Carer experience of end-of-life service provision: a social network analysis.

Leonard R, Horsfall D, Rosenberg J, Noonan K.

BMJ Support Palliat Care. 2018 Feb 10. pii: bmjspcare-2017-001344. doi: 10.1136/bmjspcare-2017-001344. [Epub ahead of print]

PMID:
29440050
3.

Experiencing recovery: findings from a qualitative study into mental illness, self and place.

Horsfall D, Paton J, Carrington A.

J Ment Health. 2018 Aug;27(4):307-313. doi: 10.1080/09638237.2017.1385736. Epub 2017 Oct 5.

PMID:
28980488
4.

Informal care networks' views of palliative care services: Help or hindrance?

Rosenberg JP, Horsfall D, Leonard R, Noonan K.

Death Stud. 2018 Jul;42(6):362-370. doi: 10.1080/07481187.2017.1350216. Epub 2017 Jul 28.

PMID:
28678634
5.

Home as a place of caring and wellbeing? A qualitative study of informal carers and caring networks lived experiences of providing in-home end-of-life care.

Horsfall D, Leonard R, Rosenberg JP, Noonan K.

Health Place. 2017 Jul;46:58-64. doi: 10.1016/j.healthplace.2017.04.003. Epub 2017 May 9.

PMID:
28499149
6.

Blurring reality with fiction: Exploring the stories of women, madness, and infanticide.

Jefferies D, Horsfall D, Schmied V.

Women Birth. 2017 Feb;30(1):e24-e31. doi: 10.1016/j.wombi.2016.07.001. Epub 2016 Jul 18.

PMID:
27444643
7.

Medical tourism: A snapshot of evidence on treatment abroad.

Lunt N, Horsfall D, Hanefeld J.

Maturitas. 2016 Jun;88:37-44. doi: 10.1016/j.maturitas.2016.03.001. Epub 2016 Mar 11. Review.

PMID:
27105695
8.

OA20 The positioning of family, friends, community, and service providers in support networks for caring at end-of-life: a social network analysis.

Leonard R, Horsfall D, Rosenberg J, Noonan K.

BMJ Support Palliat Care. 2015 Apr;5 Suppl 1:A6-7. doi: 10.1136/bmjspcare-2015-000906.20.

PMID:
25960532
9.

OA45 A different kettle of fish: death literacy.

Noonan K, Horsfall D, Leonard R, Rosenberg J.

BMJ Support Palliat Care. 2015 Apr;5 Suppl 1:A14. doi: 10.1136/bmjspcare-2015-000906.45.

PMID:
25960467
10.

OA31 Help or hindrance: how are services and systems viewed by informal care networks?

Rosenberg J, Horsfall D, Leonard R, Noonan K.

BMJ Support Palliat Care. 2015 Apr;5 Suppl 1:A10. doi: 10.1136/bmjspcare-2015-000906.31.

PMID:
25960453
11.

Love stories: understanding the caring journeys of aged Greek-Australian carers.

Horsfall D, Blignault I, Perry A, Antonopoulos P.

Health Soc Care Community. 2016 Mar;24(2):194-202. doi: 10.1111/hsc.12206. Epub 2015 Feb 23.

PMID:
25706511
12.

Forged by fire: Margery Kempe's account of postnatal psychosis.

Jefferies D, Horsfall D.

Lit Med. 2014 Fall;32(2):348-64. No abstract available.

PMID:
25693316
13.

Implications for the NHS of inward and outward medical tourism: a policy and economic analysis using literature review and mixed-methods approaches.

Lunt N, Smith RD, Mannion R, Green ST, Exworthy M, Hanefeld J, Horsfall D, Machin L, King H.

Southampton (UK): NIHR Journals Library; 2014 Jan.

14.

What do we know about medical tourism? A review of the literature with discussion of its implications for the UK National Health Service as an example of a public health care system.

Hanefeld J, Smith R, Horsfall D, Lunt N.

J Travel Med. 2014 Nov-Dec;21(6):410-7. doi: 10.1111/jtm.12147. Epub 2014 Aug 25. Review.

15.

Why do medical tourists travel to where they do? The role of networks in determining medical travel.

Hanefeld J, Lunt N, Smith R, Horsfall D.

Soc Sci Med. 2015 Jan;124:356-63. doi: 10.1016/j.socscimed.2014.05.016. Epub 2014 Jun 21.

PMID:
24976006
16.

Circles of care: should community development redefine the practice of palliative care?

Abel J, Walter T, Carey LB, Rosenberg J, Noonan K, Horsfall D, Leonard R, Rumbold B, Morris D.

BMJ Support Palliat Care. 2013 Dec;3(4):383-8. doi: 10.1136/bmjspcare-2012-000359. Epub 2013 Mar 6.

PMID:
24950517
17.

Identifying changes in the support networks of end-of-life carers using social network analysis.

Leonard R, Horsfall D, Noonan K.

BMJ Support Palliat Care. 2015 Jun;5(2):153-9. doi: 10.1136/bmjspcare-2012-000257. Epub 2013 Nov 19.

18.

Medical tourism: a cost or benefit to the NHS?

Hanefeld J, Horsfall D, Lunt N, Smith R.

PLoS One. 2013 Oct 24;8(10):e70406. doi: 10.1371/journal.pone.0070406. eCollection 2013.

19.

The UK is a net exporter of patients.

Hanefeld J, Smith R, Lunt N, Horsfall D.

BMJ. 2013 Feb 12;346:f669. doi: 10.1136/bmj.f669. No abstract available.

20.

Discussion on banning advertising of cosmetic surgery needs to consider medical tourists.

Hanefeld J, Lunt N, Horsfall D, Smith R.

BMJ. 2012 Nov 26;345:e7997. doi: 10.1136/bmj.e7997. No abstract available.

21.

Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.

Bianco-Miotto T, Chiam K, Buchanan G, Jindal S, Day TK, Thomas M, Pickering MA, O'Loughlin MA, Ryan NK, Raymond WA, Horvath LG, Kench JG, Stricker PD, Marshall VR, Sutherland RL, Henshall SM, Gerald WL, Scher HI, Risbridger GP, Clements JA, Butler LM, Tilley WD, Horsfall DJ, Ricciardelli C; Australian Prostate Cancer BioResource.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2611-22. doi: 10.1158/1055-9965.EPI-10-0555. Epub 2010 Sep 14.

22.

Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies.

Ricciardelli C, Bianco-Miotto T, Jindal S, Dodd TJ, Cohen PA, Marshall VR, Sutherland PD, Samaratunga H, Kench JG, Dong Y, Wang H, Clements JA, Risbridger GP, Sutherland RL, Tilley WD, Horsfall DJ; Australian Prostate Cancer BioResource.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1755-65. doi: 10.1158/1055-9965.EPI-10-0059.

23.

Standard preanalytical coding for biospecimens: defining the sample PREanalytical code.

Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, DeSouza Y, Eliason J, Glazer B, Guadagni F, Harding K, Horsfall DJ, Kleeberger C, Nanni U, Prasad A, Shea K, Skubitz A, Somiari S, Gunter E; International Society for Biological and Environmental Repositories (ISBER) Working Group on Biospecimen Science.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1004-11. doi: 10.1158/1055-9965.EPI-09-1268. Epub 2010 Mar 23.

24.

Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome.

Callen DF, Ricciardelli C, Butler M, Stapleton A, Stahl J, Kench JG, Horsfall DJ, Tilley WD, Schulz R, Nesland JM, Neilsen PM, Kumar R, Holm R.

Oncol Rep. 2010 Apr;23(4):1045-52.

PMID:
20204290
25.

Human biospecimen research: experimental protocol and quality control tools.

Betsou F, Barnes R, Burke T, Coppola D, Desouza Y, Eliason J, Glazer B, Horsfall D, Kleeberger C, Lehmann S, Prasad A, Skubitz A, Somiari S, Gunter E; [International Society for Biological and Environmental Repositories (ISBER) Working Group on Biospecimen Science].

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1017-25. doi: 10.1158/1055-9965.EPI-08-1231. Epub 2009 Mar 31. Review. No abstract available.

26.

Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome.

Ricciardelli C, Sakko AJ, Stahl J, Tilley WD, Marshall VR, Horsfall DJ.

Prostate. 2009 May 15;69(7):761-9. doi: 10.1002/pros.20926.

PMID:
19189303
27.

The biological role and regulation of versican levels in cancer.

Ricciardelli C, Sakko AJ, Ween MP, Russell DL, Horsfall DJ.

Cancer Metastasis Rev. 2009 Jun;28(1-2):233-45. doi: 10.1007/s10555-009-9182-y. Review.

PMID:
19160015
28.

Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse.

Sakko AJ, Butler MS, Byers S, Reinboth BJ, Stahl J, Kench JG, Horvath LG, Sutherland RL, Stricker PD, Henshall SM, Marshall VR, Tilley WD, Horsfall DJ, Ricciardelli C.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2488-97. doi: 10.1158/1055-9965.EPI-08-0204.

29.

Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.

Ricciardelli C, Jackson MW, Choong CS, Stahl J, Marshall VR, Horsfall DJ, Tilley WD.

Prostate. 2008 Jun 1;68(8):830-8. doi: 10.1002/pros.20747.

PMID:
18324648
30.

The reproducibility of transcranial Doppler middle cerebral artery velocity measurements: implications for clinical practice.

McMahon CJ, McDermott P, Horsfall D, Selvarajah JR, King AT, Vail A.

Br J Neurosurg. 2007 Feb;21(1):21-7.

PMID:
17453770
31.

Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.

Ricciardelli C, Russell DL, Ween MP, Mayne K, Suwiwat S, Byers S, Marshall VR, Tilley WD, Horsfall DJ.

J Biol Chem. 2007 Apr 6;282(14):10814-25. Epub 2007 Feb 9.

32.

Changes in steroid receptors and proteoglycan expression in the guinea pig prostate stroma during puberty and hormone manipulation.

Sakko AJ, Ricciardelli C, Mayne K, Dours-Zimmermann MT, Zimmermann DR, Neufing P, Tilley WD, Marshall VR, Horsfall DJ.

Prostate. 2007 Feb 15;67(3):288-300.

PMID:
17192879
33.

Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.

Buchanan G, Birrell SN, Peters AA, Bianco-Miotto T, Ramsay K, Cops EJ, Yang M, Harris JM, Simila HA, Moore NL, Bentel JM, Ricciardelli C, Horsfall DJ, Butler LM, Tilley WD.

Cancer Res. 2005 Sep 15;65(18):8487-96.

34.

Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.

Ricciardelli C, Choong CS, Buchanan G, Vivekanandan S, Neufing P, Stahl J, Marshall VR, Horsfall DJ, Tilley WD.

Prostate. 2005 Apr 1;63(1):19-28.

PMID:
15378523
35.

Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.

Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, LeBaron RG, Raymond WA, Tilley WD, Horsfall DJ.

Clin Cancer Res. 2004 Apr 1;10(7):2491-8.

36.

Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.

Hall RE, Horsfall DJ, Stahl J, Vivekanandan S, Ricciardelli C, Stapleton AM, Scardino PT, Neufing P, Tilley WD.

Prostate. 2004 Feb 1;58(2):103-8.

PMID:
14716735
37.

Modulation of prostate cancer cell attachment to matrix by versican.

Sakko AJ, Ricciardelli C, Mayne K, Suwiwat S, LeBaron RG, Marshall VR, Tilley WD, Horsfall DJ.

Cancer Res. 2003 Aug 15;63(16):4786-91.

38.

Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues.

Neufing PJ, Kalionis B, Horsfall DJ, Ricciardelli C, Stahl J, Vivekanandan S, Raymond W, Tilley WD.

Anticancer Res. 2003 Mar-Apr;23(2B):1479-88.

PMID:
12820413
39.

Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer.

Ricciardelli C, Brooks JH, Suwiwat S, Sakko AJ, Mayne K, Raymond WA, Seshadri R, LeBaron RG, Horsfall DJ.

Clin Cancer Res. 2002 Apr;8(4):1054-60.

40.

A potential autocrine role for vascular endothelial growth factor in prostate cancer.

Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.

Cancer Res. 2002 Feb 1;62(3):854-9. Erratum in: Cancer Res 2002 Apr 1;62(7):2200.

41.

Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.

Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG, Horsfall DJ.

Cancer Res. 2001 Feb 1;61(3):926-30.

42.

Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function.

Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD.

Mol Endocrinol. 2001 Jan;15(1):46-56.

PMID:
11145738
43.

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.

Bentel JM, Birrell SN, Pickering MA, Holds DJ, Horsfall DJ, Tilley WD.

Mol Cell Endocrinol. 1999 Aug 20;154(1-2):11-20.

PMID:
10509795
44.

A simple index using video image analysis to predict disease outcome in primary breast cancer.

Lockwood CA, Ricciardelli C, Raymond WA, Seshadri R, McCaul K, Horsfall DJ.

Int J Cancer. 1999 Jun 21;84(3):203-8.

45.

Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer.

Ricciardelli C, Quinn DI, Raymond WA, McCaul K, Sutherland PD, Stricker PD, Grygiel JJ, Sutherland RL, Marshall VR, Tilley WD, Horsfall DJ.

Cancer Res. 1999 May 15;59(10):2324-8.

46.

Immunolocalization of apolipoprotein D, androgen receptor and prostate specific antigen in early stage prostate cancers.

Zhang SX, Bentel JM, Ricciardelli C, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD.

J Urol. 1998 Feb;159(2):548-54.

PMID:
9649289
47.

Tumor microvascularity has no independent prognostic significance for breast cancer.

Mayers MM, Seshadri R, Raymond W, McCaul K, Horsfall DJ.

Pathology. 1998 May;30(2):105-10.

PMID:
9643487
48.

Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer.

Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, Marshall VR, Horsfall DJ.

Clin Cancer Res. 1998 Apr;4(4):963-71.

49.

A simple index to predict prognosis independent of axillary node information in breast cancer.

Seshadri R, Horsfall DJ, McCaul K, Leong AS.

Aust N Z J Surg. 1997 Nov;67(11):765-70.

PMID:
9396991
50.

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.

Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R, Sutherland RL.

Oncogene. 1997 Sep 25;15(13):1617-23.

Supplemental Content

Loading ...
Support Center